| 31st Jan 2023 12:01 pm |
RNS |
Ondine’s APDT reduces SARS-CoV-2 infectivity |
| 17th Jan 2023 10:04 am |
RNS |
TR-1: Notification of major holdings |
| 17th Jan 2023 9:30 am |
RNS |
New photodisinfection study published |
| 13th Jan 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 13th Jan 2023 4:35 pm |
RNS |
Price Monitoring Extension |
| 30th Dec 2022 12:31 pm |
RNS |
Appointment of Nominated Adviser |
| 12th Dec 2022 7:00 am |
RNS |
Steriwave receives regulatory approval in Mexico |
| 5th Dec 2022 7:00 am |
RNS |
Ondine receives funding for meat photodisinfection |
| 2nd Dec 2022 6:25 pm |
RNS |
Ondine receives funding for meat photodisinfection |
| 2nd Dec 2022 7:00 am |
RNS |
Ondine reports full results from Phase 2 trial |
| 21st Nov 2022 7:00 am |
RNS |
Ondine appoints Spanish distributer for Steriwave |
| 7th Nov 2022 9:02 am |
RNS |
Ondine cuts COVID-19 rate in food processing plant |
| 4th Nov 2022 7:00 am |
RNS |
PDMR Dealing |
| 31st Oct 2022 11:18 am |
RNS |
Ondine CTO receives Lifetime Achievement Award |
| 28th Oct 2022 7:00 am |
RNS |
PDMR Dealing |
| 19th Oct 2022 12:07 pm |
RNS |
Ondine presents new efficacy data against MRSA |
| 19th Oct 2022 11:36 am |
RNS |
Steriwave™ cuts SSI risk by 47% at major hospital |
| 11th Oct 2022 7:00 am |
RNS |
Investor Presentation |
| 27th Sep 2022 7:00 am |
RNS |
Interim results for the six months to 30 June 2022 |
| 23rd Sep 2022 9:00 am |
RNS |
The Ottawa Hospital pilots nasal disinfection |
| 20th Sep 2022 9:34 am |
RNS |
New research presented on photodisinfection |
| 7th Sep 2022 12:30 pm |
RNS |
Ondine’s photodisinfection kills ESKAPE pathogens |
| 6th Sep 2022 7:00 am |
RNS |
Ondine reports successful US Phase 2 trial data |
| 31st Aug 2022 10:49 am |
RNS |
Nature reports Ondine therapy suppresses COVID-19 |
| 16th Aug 2022 7:00 am |
RNS |
Ondine appoints RBC and Singer as joint brokers |
| 8th Aug 2022 10:02 am |
RNS |
Ondine completes US Phase II trial recruitment |
| 26th Jul 2022 7:00 am |
RNS |
Completion of Nominated Adviser due diligence |
| 22nd Jul 2022 7:00 am |
RNS |
Issue of Equity |
| 19th Jul 2022 7:00 am |
RNS |
Ondine completes successful SARS-CoV-2 trial |
| 8th Jun 2022 7:00 am |
RNS |
Result of AGM |
| 7th Jun 2022 7:00 am |
RNS |
Posting of annual report |
| 19th May 2022 7:00 am |
RNS |
Full Year Results to 31 December 2021 |
| 17th May 2022 7:00 am |
RNS |
Notice of AGM |
| 10th May 2022 10:30 am |
RNS |
WHO calls for better infection prevention |
| 27th Apr 2022 4:30 pm |
RNS |
Appointment of Nominated Adviser |
| 5th Apr 2022 7:00 am |
RNS |
Photodisinfection effective against SARS-CoV-2 |
| 21st Feb 2022 7:00 am |
RNS |
Grant of Options and PDMR Dealing |
| 7th Feb 2022 7:00 am |
RNS |
Ondine treats first patients in Phase 2 FDA trial |
| 20th Dec 2021 7:00 am |
RNS |
Ondine and University of Navarra initiate clinical |
| 15th Dec 2021 7:00 am |
RNS |
Ondine Biomedical appoints Professor Trevor Jones |
